A Phase II, Open-Label Study to Assess Safety and Management Change Using 68 Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study (2021)

First Author: Afaq A
Attributed to:  Next generation molecular imaging and therapy with radionuclides funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.120.257527

PubMed Identifier: 33741648

Publication URI: http://europepmc.org/abstract/MED/33741648

Type: Journal Article/Review

Parent Publication: Journal of Nuclear Medicine

Issue: 12

ISSN: 0161-5505